BridgeMD
New treatment option for Breast Cancer Invasive
Official title AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
ClinicalTrials.gov ID: NCT05351424
What this study is testing
- What it's testing
- The study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation therapy and to foster receptivity and informed decision-making around cancer clinical trial participation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Pilot Phase
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South...
- Currently undergoing treatment for breast or prostate cancer, or recently been treated Pilot Phase
You likely can't join if
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia Main Study Inclusion Criteria:
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South...
- Patients with non-metastatic prostate or breast cancer
- Histopathologically proven diagnosis of prostate or breast cancer
- History and physical examination within 28 days prior to enrollment
See the full eligibility criteria
- Pilot Phase
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Currently undergoing treatment for breast or prostate cancer, or recently been treated Pilot Phase
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia Main Study Inclusion Criteria:
- Spanish speakers of Latinx background as defined by the U.S. Census Bureau as anyone from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry
- Patients with non-metastatic prostate or breast cancer
- Histopathologically proven diagnosis of prostate or breast cancer
- History and physical examination within 28 days prior to enrollment
- Karnofsky performance status 70 or greater
- For women of childbearing potential, pregnancy testing to be performed in accordance to institutional guidelines
- Plan to receive definitive, curative radiation. Patients planning to receive curative RT after upcoming adjuvant chemotherapy or induction hormonal therapy may enroll at reconsult "follow-up" visit.
- Consultation visit must be performed with a certified interpreter Main Study Exclusion Criteria:
- Patient with bilateral deafness and/or blindness
- Patient with psychosis and/or dementia
- Clinical or radiological evidence of metastatic disease
- Prior participation in cancer patient education trial
- Prior RT
- RT for sites other than breast or prostate
The study team makes the final eligibility decision.
Where it's taking place
- Miami Beach, Florida, United States
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Miami Beach, Florida, United States; New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.